Data as of Apr 17
| +0.01 / +0.11%|
The 5 analysts offering 12-month price forecasts for GenMark Diagnostics Inc have a median target of 17.00, with a high estimate of 17.00 and a low estimate of 14.00. The median estimate represents a +80.08% increase from the last price of 9.44.
The current consensus among 6 polled investment analysts is to Buy stock in GenMark Diagnostics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.